stockrowEnovis Corporation (ENOV) vs Tandem Diabetes Care, Inc. (TNDM)
- Enovis Corporation ENOV 27.07 −5.42%
- Tandem Diabetes Care, Inc. TNDM 16.78 −6.73%
Enovis Corporation and Tandem Diabetes Care, Inc. are both Medical Devices companies. Enovis Corporation is the larger, with a market value of $1.7B against $1.3B — 1.3× the size. Tandem Diabetes Care, Inc. grew revenue faster over the last twelve months: 6.84% against 3.28%. Tandem Diabetes Care, Inc. has the higher net margin (−4.58% vs −22.9%) and the higher return on invested capital (−5.35% vs −10.8%). Across the 18 metrics below, Enovis Corporation leads on 9 and Tandem Diabetes Care, Inc. on 9.
Valuation
Profitability
| Metric | ENOV | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 61.31% | 56.65% | 57.76% |
| Operating margin | (20.59%) | (2.35%) | (15.07%) |
| Net margin | (22.87%) | (4.58%) | (14.45%) |
| Free cash flow margin | 3.02% | (3.37%) | (3.88%) |
| Return on equity | (29.97%) | (36.74%) | (10.35%) |
| Return on assets | (12.91%) | (4.84%) | (17.26%) |
| Return on invested capital | (10.83%) | (5.35%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack